Editas Medicine Inc. revenue breakdown overview

Editas Medicine Inc. revenue for the last year amounted to 70.78 M EUR, the most of which — 70.78 M EUR — came from its highest performing source at the moment, Genome Editing Technology, the year earlier bringing 18.42 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Editas Medicine Inc. 70.78 M EUR, and the year before that — 18.42 M EUR.